| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070037833 Compositions and methods for inhibiting neurodegeneration |
| 02/15/2007 | US20070037832 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 02/15/2007 | US20070037831 Methods of using PDE 5 inhibitors for the treatment of congestive heart failure |
| 02/15/2007 | US20070037830 2-Adamantyl derivatives as p2X7 receptor antagonists. |
| 02/15/2007 | US20070037829 e.g. trans-(4-Phenethyloxy-cyclohexyl)-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine; neurodegenerative disorders, analgesic, antidepressant, anxiolytic agent; Parkinson's disease, Alzheimer's disease, epilepsy, ischemic brain injury, stroke; with other active ingredients |
| 02/15/2007 | US20070037828 Pyrazolopyrimidines |
| 02/15/2007 | US20070037827 Sirtuin modulating compounds |
| 02/15/2007 | US20070037826 Indolylmaleimide derivatives |
| 02/15/2007 | US20070037825 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 02/15/2007 | US20070037824 Enzyme inhibitors from pyrazolo[1,5a]pyrimidine as enzyme inhibitors |
| 02/15/2007 | US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 02/15/2007 | US20070037822 Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 02/15/2007 | US20070037821 Nitrosated glutamic acid compounds, compositions and methods of use |
| 02/15/2007 | US20070037820 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/15/2007 | US20070037819 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
| 02/15/2007 | US20070037818 Discovery of valuable properties for the primary energy source "PES 2000 plus Folic Acid" |
| 02/15/2007 | US20070037817 Acetylenic piperazines as metabotropic glutamate receptor antagonists |
| 02/15/2007 | US20070037816 Bicyclic piperazines as metabotropic glutatmate receptor antagonists |
| 02/15/2007 | US20070037815 Novel pharmaceutical compounds |
| 02/15/2007 | US20070037814 ACYLSULFAMIDE INHIBITORS OF FACTOR VIIa |
| 02/15/2007 | US20070037813 Serine Protease Inhibitors |
| 02/15/2007 | US20070037812 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis |
| 02/15/2007 | US20070037811 Hiv inhibiting 1,2,4-triazines |
| 02/15/2007 | US20070037810 Sirtuin modulating compounds |
| 02/15/2007 | US20070037809 histone deacetylase inhibitors, used for treating preventing diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood disorders, inflammation, cancer, and/or hot flashes |
| 02/15/2007 | US20070037808 Anti-inflammatory medicaments |
| 02/15/2007 | US20070037807 Pyridine compounds as inhibitors of dipeptidyl peptidase IV |
| 02/15/2007 | US20070037806 Pyrrolidine derivatives as oxytocin antagonists |
| 02/15/2007 | US20070037805 Fused heteroaryl derivatives |
| 02/15/2007 | US20070037804 Imidazolone phenylalanine derivatives |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037802 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/15/2007 | US20070037801 Novel indoles are cannabinoid receptor ligands |
| 02/15/2007 | US20070037800 Method of treating neurological disorders using clotrimazole and derivatives thereof |
| 02/15/2007 | US20070037798 Thiolactones |
| 02/15/2007 | US20070037797 Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events |
| 02/15/2007 | US20070037796 e.g. 7-Phenyl-isoquinoline-5-sulfonic acid {2-[3 -(4-nitrophenyl)-propylamino]-ethyl}-amide, dihydrochloride salt; antiviral, antineoplastic, anticarcinogenic agents; neoplasms |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037794 Heteroaryl sulfonamides and CCR2 |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037792 Pharmaceutical compositions |
| 02/15/2007 | US20070037791 serine/threonine kinase inhibitors, useful for therapy and/or prophylaxis of cancers in mammals |
| 02/15/2007 | US20070037790 Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/15/2007 | US20070037789 4-chloro-N-((R)-5,5-difluoro-2-oxo-azepan-3-yl)-N-[2-fluoro-4-(2H-[1,2,4]triazol-3-yl)-benzyl]-benzenesulfonamide; gamma -secretase inhibitor; neurodegenerative diseases; Alzheimer's disease; anticarcinogenic agent; cervical carcinomas and breast carcinomas and malignancies of the hematotic system |
| 02/15/2007 | US20070037788 5-(3,8-Difluoro-6H-dibenzo[b,e]oxepin-11-ylidenemethyl)-1-(1-ethyl-pyrrolidin-3-yl) -1,3-dihydro-benzoimidazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia |
| 02/15/2007 | US20070037787 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/15/2007 | US20070037786 Cephem compounds |
| 02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 02/15/2007 | US20070037784 Ring structures C6.C6.C13N and C6.C6.C12NO |
| 02/15/2007 | US20070037783 Migrastatin analogs and uses thereof |
| 02/15/2007 | US20070037782 Therapeutic agent for ageing macular degeneration |
| 02/15/2007 | US20070037781 Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient |
| 02/15/2007 | US20070037780 Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith |
| 02/15/2007 | US20070037779 Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof |
| 02/15/2007 | US20070037778 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide |
| 02/15/2007 | US20070037777 Lipid-containing compositions and methods of using them |
| 02/15/2007 | US20070037776 Polysaccharides for delivery of active agents |
| 02/15/2007 | US20070037775 drugs having a high receptivity for hemagglutinins, used for diagnosis and therapy of bacterial infections |
| 02/15/2007 | US20070037774 Novel cytarabine monophosphate prodrugs |
| 02/15/2007 | US20070037773 Methods and compositions for treating flaviviruses and pestiviruses |
| 02/15/2007 | US20070037772 Pyrazolidinol compounds |
| 02/15/2007 | US20070037771 Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates |
| 02/15/2007 | US20070037770 Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use |
| 02/15/2007 | US20070037767 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 02/15/2007 | US20070037765 gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 02/15/2007 | US20070037764 Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells |
| 02/15/2007 | US20070037758 Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics |
| 02/15/2007 | US20070037757 Erythromycin scaffolds substituted at the 4'' position: 4'-O-[3-[[2-[(3-carboxy-7-chloro-1-cyclopropyl-1,4-dihydro-4-oxo-6-quinolinyl) amino]ethyl]amino]propionyl]-11-O-(2-dimethylaminoethoxymethyl)-(9E)-methoximino erythromycin A |
| 02/15/2007 | US20070037756 Compositions and methods for the prevention and treatment of circulatory conditions |
| 02/15/2007 | US20070037755 Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/15/2007 | US20070037740 Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis |
| 02/15/2007 | US20070037739 Compounds useful in coating stents to prevent and treat stenosis and restenosis |
| 02/15/2007 | US20070037738 Using Inhibitors of Histone Deacetylases for the Suppression Therapy of Inherited Disease Predisposing Conditions |
| 02/15/2007 | US20070037737 Composition and method for the repair and regeneration of cartilage and other tissues |
| 02/15/2007 | US20070037735 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/15/2007 | US20070037710 Use of guanidine compounds as physiological strengthening agents in the form of nutritional supplements, animal feed additives, in cosmetic preparations and as plant stimulants |
| 02/15/2007 | US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system |
| 02/15/2007 | US20070037218 Human gene critical to fertility |
| 02/15/2007 | US20070037202 Potentiation of cancer therapies by ZNF217 inhibition |
| 02/15/2007 | US20070037159 Tetrahydrofolate synthetase gene |
| 02/15/2007 | US20070036876 Relieving pain at a body site by administering a dosage of capsaicinoid at the painful site without eliciting an effect outside the discrete location; local anesthetic effect; targeted therapy |
| 02/15/2007 | US20070036875 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent |
| 02/15/2007 | US20070036874 Compositions and methods for controlling glucose and lipid uptake from foods |
| 02/15/2007 | US20070036870 Aiding of cognitive function |
| 02/15/2007 | US20070036869 Methods for prophylactic and therapeutic nutritional supplementation |
| 02/15/2007 | US20070036868 oily vitamin derivatives, gelling agent such as agarose, carrageenan and carrageenan-carob mixture, and protein, except gelatine; preparing solution or suspension, forming oil in water emulsion, adding to vegetable oil to for oil-water-oil emulsion, solidifying, cooling, drying |
| 02/15/2007 | US20070036867 Controlled and Sustained Gene Transfer Mediated by Thiol-Modified Polymers |
| 02/15/2007 | US20070036863 Oxacarbazepine film-coated tablets |
| 02/15/2007 | US20070036862 Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof |
| 02/15/2007 | US20070036860 Treatment of allergic conditions |
| 02/15/2007 | US20070036859 Sustained release antihistamine and decongestant composition |
| 02/15/2007 | US20070036857 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin |
| 02/15/2007 | US20070036856 Diltiazem controlled release formulation and method of manufacture |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036853 Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 02/15/2007 | US20070036852 Rapidly dispersing/disintegrating compositions |
| 02/15/2007 | US20070036851 Acid labile drug compositions |
| 02/15/2007 | US20070036850 Film-coated tablet or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this compound |